AFP and hepatocellular carcinoma: Although these studies demonstrated the potential of VOCs as biomarkers for HCC diagnosis, the performance of VOCs compared to AFP has yet to be investigated, and whether VOCs can be used to monitor treatment response and determine the prognosis of HCC patients remains unknown.